Le Lézard
Classified in: Health
Subjects: NPT, WOM, MAT

Dr. Christopher Walker and Hazel Walker Foundation Supports Women's Health with Donations to Local and International Charities


Nonprofit supports underserved and minority women by giving back to community health care organizations

ORLANDO, Fla., Sept. 8, 2022 /PRNewswire-PRWeb/ -- Hazel Walker Foundation (HWF), a nonprofit organization offering no-cost reproductive health services, information, and education for women, has made monetary donations to charities in the U.S. and aboard. The charitable contributions are a part of the organization's ongoing effort to support women in underserved communities. Founder Dr. Christopher Walker selected Women's Health Network in Jamaica and Shepherd's Hope in Central Florida as the first recipients to obtain financial assistance through the organization.

In addition to its core mission, Hazel Walker Foundation aids facilities, clinics, and programs that deliver free sexual and reproductive health care. Women's Health Network is a not-for-profit, non-governmental organization (NGO) in Jamaica, West Indies with mission and service sites across the island. The organization increases access to essential healthcare services and ensures equity in the delivery of services. Shepherd's Hope provides free primary care and specialty care medical services to uninsured and underinsured patients. With funding from HWF, both charities can extend their services and reach more women in the communities they serve.

"Even as a small nonprofit, we have the capability to make a global impact by donating to organizations, in the United States and abroad, that closely align with our mission," says Dr. Christopher Walker, founder of the Hazel Walker Foundation. "Women's Health Network and Shepherd's Hope address barriers that prevent financially disadvantaged women from getting critical reproductive and sexual health care."

Hazel Walker Foundation empowers women to take control of their reproductive health by offering free oral contraceptives. The nonprofit also helps victims of female genital mutilation (FGM) by performing no-cost reconstructive surgery. All services are delivered through the through the foundation's partner provider UroGyn Specialists of Florida in downtown Orlando, and additional information is available via the website. Over the next few months, the website is expected to expand educational resources, such as videos, articles, and links to medical facilities and public health services across the nation.

About Hazel Walker Foundation
Hazel Walker Foundation, Inc. (HWF) is a nonprofit organization that supports women's reproductive health by offering free services and educational resources. Dr. Christopher Walker, a humanitarian and nationally recognized urogynecologist and regenerative medicine specialist, founded the organization in honor of his mother, Hazel Walker. The nonprofit is a legacy of her motherly love, support, and strong Christian values and will advance the right to universal sexual and reproductive health care for all women. To learn more, visit HazelWalkerFoundation.org.

Media Contact

Nicole Blake-Baxter, The Blake Agency, 1 (678)957-7675, [email protected]

Twitter, LinkedIn

 

SOURCE Hazel Walker Foundation


These press releases may also interest you

at 05:09
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...



News published on and distributed by: